YBX1 and breast carcinoma: A group of i-tRFs derived from tRNAGlu, tRNAAsp, tRNAGly, and tRNATyr compete with YBX1 to bind to the 3’UTRs of multiple oncogenic transcripts in breast cancer cells, thus eliminating the stabilization effect of YBX1 [42].